# Polyneuropathy, Inflammatory Demyelinating, Chronic FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/polyneuropathy-inflammatory-demyelinating-chronic

> 2 upcoming FDA catalysts in polyneuropathy, Inflammatory Demyelinating, Chronic: riliprubart prefilled pen (pfp, SNY) on Oct 2029 to Jan 2030 (topline data readout); riliprubart prefilled pen (pfp, SNY) on October 2029 (primary completion).

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: quarter only, month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Oct 2029 to Jan 2030 | [Riliprubart prefilled pen (pfp) topline data readout](https://sec-api.dev/pdufa/riliprubart-prefilled-pen-pfp) | SNY | Polyneuropathy, Inflammatory Demyelinating, Chronic | scheduled | "NCT06859099 (Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP): Overall Status ENROLLING_BY_INVITATION; Phase PHASE3; Primary Completion 2029-10-03 (ESTIMATED); Lead Sponsor Sanofi." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06859099)) |
| October 2029 | [Riliprubart prefilled pen (pfp) primary completion](https://sec-api.dev/pdufa/riliprubart-prefilled-pen-pfp) | SNY | Polyneuropathy, Inflammatory Demyelinating, Chronic | scheduled | "NCT06859099 (Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP): Overall Status ENROLLING_BY_INVITATION; Phase PHASE3; Primary Completion 2029-10-03 (ESTIMATED); Lead Sponsor Sanofi." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06859099)) |

## Drugs

- [Riliprubart prefilled pen (pfp)](https://sec-api.dev/pdufa/riliprubart-prefilled-pen-pfp) (SNY)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/polyneuropathy-inflammatory-demyelinating-chronic.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Polyneuropathy, Inflammatory Demyelinating, Chronic FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/polyneuropathy-inflammatory-demyelinating-chronic

```bibtex
@misc{secapidev_indications_polyneuropathy_inflammatory_demyelinating_chronic_20261116,
  title        = {Polyneuropathy, Inflammatory Demyelinating, Chronic FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/polyneuropathy-inflammatory-demyelinating-chronic}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_polyneuropathy_inflammatory_demyelinating_chronic_20261116","title":"Polyneuropathy, Inflammatory Demyelinating, Chronic FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/polyneuropathy-inflammatory-demyelinating-chronic","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
